These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 16772742

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J, Zimny A, Knysz B, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ.
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM, Heinze HJ, Kaufmann J.
    J Alzheimers Dis; 2013 Oct; 36(1):155-63. PubMed ID: 23579327
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.
    Auer DP, Wilke M, Grabner A, Heidenreich JO, Bronisch T, Wetter TC.
    Schizophr Res; 2001 Oct 01; 52(1-2):87-99. PubMed ID: 11595395
    [Abstract] [Full Text] [Related]

  • 11. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M, Moriya M, Nojo T.
    J Alzheimers Dis; 2017 Oct 01; 60(4):1411-1427. PubMed ID: 28968236
    [Abstract] [Full Text] [Related]

  • 12. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
    Murray ME, Przybelski SA, Lesnick TG, Liesinger AM, Spychalla A, Zhang B, Gunter JL, Parisi JE, Boeve BF, Knopman DS, Petersen RC, Jack CR, Dickson DW, Kantarci K.
    J Neurosci; 2014 Dec 03; 34(49):16247-55. PubMed ID: 25471565
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy.
    Lazeyras F, Charles HC, Tupler LA, Erickson R, Boyko OB, Krishnan KR.
    Psychiatry Res; 1998 May 20; 82(2):95-106. PubMed ID: 9754452
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability.
    Wiedermann D, Schuff N, Matson GB, Soher BJ, Du AT, Maudsley AA, Weiner MW.
    Magn Reson Imaging; 2001 Oct 20; 19(8):1073-80. PubMed ID: 11711231
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.